KV Pharma (KV-A) Pops 25+% After Doctors Group Said Makena, Compounds Differ
Tweet
Share
E-mail
KV Pharma (NYSE: KV-A) shares rose following report that a doctors group said Makena, compounds differ.
Shares rose as much as 30 percent.
Shares rose as much as 30 percent.
Create E-mail Alert Related Categories
FDA, Insiders' Blog, Momentum MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
